Financing type:  underwritten prospectus offering

Gross proceeds:  $18,993,500

Offering:  32,747,414 listed shares

Offering price:  58 cents per listed share

Warrant exercise terms:  not applicable

Overallotment option:  The underwriters were granted an option to purchase a maximum of 4,525,862 listed shares. As of June 12, 2026, 2,575,000 listed shares have been issued thereunder. All information presented herein includes such exercise. The overallotment option with respect to the balance of the shares expires on July 9, 2026.

Commissions in securities:  not applicable

Disclosure:  Refer to the prospectus supplement dated June 4, 2026, as incorporated by reference into the short form base shelf prospectus dated April 8, 2026, and the company's news releases dated June 2, 2026, June 3, 2026, June 8, 2026, and June 9, 2026.